Next, the m6A regulator HNRNPC was selected as the most influential predictor for NSCLC, and HNRNPC predicted poor prognosis and correlated with tumor invasion and lymph node metastasis. Here, METTL3 is linked to metastatic malignant neoplasm in the lymph nodes.